靶点- |
作用机制- |
|
|
|
|
最高研发阶段批准上市 |
|
首次获批日期1979-04-01 |
|
|
|
|
|
非在研适应症- |
最高研发阶段批准上市 |
|
首次获批日期1951-12-31 |
A Phase 2a double blind, randomised, placebo controlled, two dose study to determine the effect of orally administered methylnaltrexone (MNTX) in preventing post-operative opiate induced constipation in patients undergoing elective orthopaedic surgery - Coated MNTX
A Phase IV, Multi-centre, Double-blind, Randomised, Placebo-controlled Parallel Group Study to Compare the Efficacy and Safety of MOVICOL® with Placebo in Patients with Constipation Associated with Irritable Bowel Syndrome (IBS)
100 项与 Norgine Pharmaceuticals Ltd. 相关的临床结果
0 项与 Norgine Pharmaceuticals Ltd. 相关的专利(医药)
100 项与 Norgine Pharmaceuticals Ltd. 相关的药物交易
100 项与 Norgine Pharmaceuticals Ltd. 相关的转化医学